This is common in the mixed-lineage leukemia (MLL) gene, resulting in aggressive leukemia [41], including 5–10% of adult acute leukemias [42] and 60–80% of infant acute leukemias [43]. This evidence concerns the gene KMT2A and acute leukemia.